BB Biotech AG

BION

Equity

ISIN CH0038389992 / Valor 3838999

SIX Swiss Exchange (2026-05-25)

CHF 43.74+0.23%

BB Biotech AG
UMushroom community rating:

3.75 20 votes No rating yet

NegativeNeutralPositive

About company

BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies. It focuses on the development and commercialization of novel drugs sectors. The company was founded on November 9, 1993 and is headquartered in Schaffhausen, Switzerland.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

52.0%1Y

2.20%3Y

-43.7%5Y

Performance

26.0%1Y

25.1%3Y

25.8%5Y

Volatility

3116 M

Market cap (USD)

52,090

Daily traded volume (Shares)

35.75 / 35.25

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.75

20 votes

Performance:

3.08

Innovation:

4.21

Society:

4.00

Nature:

3.42

Fabio Kull

Switzerland, 16 Mar 2026

BB Biotech is attractive because it provides diversified exposure to leading biotechnology companies developing innovative therapies. Its experienced management team and focus on high-growth biotech firms offer strong long-term investment potential.